Choline salicylate
Choline salicylate is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
No data
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| first aid shot therapy hangover relief | OTC monograph not final | 2015-06-04 |
| first aid shot therapy pain relief | OTC monograph not final | 2015-01-21 |
| kroger cough cold and flu | OTC monograph final | 2016-06-30 |
| kroger nitetime cold and flu | OTC monograph final | 2016-06-30 |
| kroger sinus pain and pressure | OTC monograph final | 2016-06-23 |
| texaclear pain and chest congestion relief | C200263 | 2024-10-07 |
| texaclear pain reliever | C200263 | 2024-10-07 |
| texaclear severe cough, cold and flu | C200263 | 2024-10-07 |
| topcare cough cold and flu simple relief | OTC monograph final | 2016-06-28 |
| topcare nighttime cold and flu simple relief | OTC monograph final | 2018-06-28 |
Show 1 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
No data
Drug
General
| Drug common name | Choline salicylate |
| INN | choline salicylate |
| Description | Choline is a choline that is the parent compound of the cholines class, consisting of ethanolamine having three methyl substituents attached to the amino function. It has a role as a neurotransmitter, a nutrient, a human metabolite, a plant metabolite, a Daphnia magna metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a mouse metabolite and an allergen. |
| Classification | Small molecule |
| Drug class | anti-inflammatory agents (salicylic acid derivatives) |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | C[N+](C)(C)CCO.O=C([O-])c1ccccc1O |
Identifiers
| PDB | — |
| CAS-ID | 2016-36-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL2104095 |
| ChEBI ID | — |
| PubChem CID | 305 |
| DrugBank | DB00122 |
| UNII ID | KD510K1IQW (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use